Sanil Bhatia

23PUBLICATIONS
116CO-AUTHORS
Haematological tumoursPharmacogenomicsInnate immunityMolecular targetsHypersonic propulsion and hypersonic aerothermodynamics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Aug 10, 2026
Measurable Residual Disease-Dependent Unfavorable Outcomes in Pediatric PAX5-Rearranged B-Acute Lymphoblastic Leukemia.

|Jul 14, 2026
Targeting Histone Acetyltransferases EP300/CBP by Novel Proline-Based PROTAC Degraders.

|Mar 07, 2026
Epigenetic remodeling via HDAC6 inhibition amplifies anti-tumoral immune responses in myeloid leukemia cells.

Julian Schliehe-Diecks, Jia-Wey Tu, Pawel Stachura

|Jan 02, 2026
Discovery of Histone Deacetylase 8-Specific Proteolysis-Targeting Chimeras with Anticancer Activity against Hematological Malignancies.

Shiyang Zhai, Marie Kemkes, Cindy-Esther Kponomaizoun

|Dec 23, 2025
Small-molecule inhibitor of C‑terminal HSP90 dimerization modulates autophagy and functions synergistically with mTOR inhibition to kill cisplatin-resistant cancer cells.

Céline David, Yadong Sun, Vitalij Woloschin

|May 21, 2025
Identification of non-charged 7.44 analogs interacting with the NHR2 domain of RUNX1-ETO with improved antiproliferative effect in RUNX-ETO positive cells.

Mohanraj Gopalswamy, David Bickel, Niklas Dienstbier

Pageof 4

Frequent Collaborators

9 joint publications

Finn K Hansen

8 joint publications

Arndt Borkhardt

5 joint publications

Thomas Kurz

5 joint publications

Holger Gohlke